Mirae Asset Global ETFs Holdings’s BridgeBio Pharma BBIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Sell	4,758 -74,174	-94%	-$5.2M	﹤0.01%	2204
2026 Q1	$5.84M	Buy	78,932 +558	+0.7%	+$40.4K	0.01%	784
2025 Q4	$5.99M	Sell	78,374 -2,042	-3%	-$134K	0.01%	757
2025 Q3	$4.18M	Sell	80,416 -14,910	-16%	-$727K	0.01%	852
2025 Q2	$4.13M	Buy	95,326 +2,206	+2%	+$80.2K	0.01%	797
2025 Q1	$3.22M	Buy	93,120 +3,126	+3%	+$105K	0.01%	900
2024 Q4	$2.47M	Buy	89,994 +3,481	+4%	+$90K	0.01%	1020
2024 Q3	$2.2M	Buy	86,513 +17,617	+26%	+$463K	﹤0.01%	1071
2024 Q2	$1.74M	Buy	+68,896	New	+$1.88M	﹤0.01%	1141

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BBIO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its BridgeBio Pharma (BBIO) stake by 94% in Q2 2026, selling an estimated $5.2M and leaving 4,758 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

Mirae Asset Global ETFs Holdings first reported a position in BBIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.99M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Mirae Asset Global ETFs Holdings held 4,758 shares of BridgeBio Pharma worth $343K as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 74,174 BridgeBio Pharma shares in Q2 2026, an estimated $5.2M.
BridgeBio Pharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2204 holding.
Mirae Asset Global ETFs Holdings first reported a position in BridgeBio Pharma in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's BridgeBio Pharma position peaked at $5.99M in Q4 2025.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.